CDK2 and breast cancer: We further showed that the expression of E2F3, CDK2 and CCNA2 transcripts are negatively correlated with expression of miR-125b but not that of the homologous miR-125a in breast cancer patients (Fig. S5D), supporting an inhibitory relationship between miR-125b and these cell cycle regulators.